duloxetine boehringer ingelheim
boehringer ingelheim international gmbh - duloxetinei - neuropatii diabetice - psychoanaleptics, - tratamentul durerii neuropatice periferice diabetice la adulți.
actilyse 50 mg
boehringer ingelheim pharma gmbh & co. kg - germania - alteplasum - pulb.+solv. pt. sol. inj./perf. - 50mg - antitrombotice enzime
glurenorm 30 mg
boehringer ingelheim hellas single member s.a. - grecia - gliquidonum - compr. - 30mg - antidiabetice orale si parenterale , exclusiv insuline sulfonamide, derivati de uree
movalis 15 mg
boehringer ingelheim pharma gmbh & co. kg - germania - meloxicamum - compr. - 15mg - antiinflamatoare si antireumatice nesteroidiene oxicami
movalis 7,5 mg
boehringer ingelheim pharma gmbh & co. kg - germania - meloxicamum - compr. - 7,5mg - antiinflamatoare si antireumatice nesteroidiene oxicami
spiriva 18 micrograme
boehringer ingelheim international gmbh - germania - tiotropium - caps. cu pulb. de inhal. - 18micrograme - alte med. pt. trat. bolilor obstructive ale c.r, inhalante anticholinergice
srivasso 18 micrograme
boehringer ingelheim pharma gmbh & co. kg - germania - tiotropium - pulbere de inhalat, caps. - 18micrograme - alte med. pt. trat. bolilor obstructive ale c.r, inhalante anticholinergice
purevax rcpch felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
actilyse 50 mg pulbere şi solvent pentru soluţie injectabilă/perfuzabilă
boehringer ingelheim international gmbh - alteplasum - pulbere şi solvent pentru soluţie injectabilă/perfuzabilă - 50 mg
ingelvac prrsflexr eu, vaccin
boehringer ingelheimvetmedica gmbh, germania - virusul - liofilizat şi solvent pentru suspensie injectabilă - suine